Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha

[Preoperative X-ray computed tomographic evaluation of major aplasia of the ear in children].

Journal de radiologie·1995

Systemic levels of tumor necrosis factor alpha during hemodialysis with cellulosic membranes: no effect of the sterilization procedure.

Artificial organs·1992

[Immunohistochemical findings in otosclerotic lesions].

HNO·1992

Quantitative assessment of urinary protein and enzyme excretion--a diagnostic programme for the detection of renal involvement in type I diabetes mellitus.

Scandinavian journal of clinical and laboratory investigation·1992

Variables associated with the assessment of systemic tumor necrosis factor alpha levels during hemodialysis.

The International journal of artificial organs·1992

Peri-operative liver graft function: monitoring using the relationship between blood glucose and oxygen consumption during anaesthesia.

Anaesthesia·1992

Hairy Cell Leukemia: 2026 Update on Diagnosis, Risk-Stratification, and Treatment.

American journal of hematology·2026

Splenic Tropism and Spleen-Modulated Systemic Inflammation in Acute Plasmodium vivax Malaria.

American journal of hematology·2026

The Presence and Percentage of Circulating Nucleated Red Blood Cells Reveal Distinct Characteristics in Adults With Sickle Cell Disease.

American journal of hematology·2026

Anticoagulant Therapy and Bleeding-Related Hospitalizations in Patients With Cancer: A National Cohort Study.

American journal of hematology·2026

Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

American journal of hematology·2026

Primary Plasma Cell Leukemia.

American journal of hematology·2026

Treatment Adherence in Haemophilia: Methods of Assessment, Clinical Outcomes, and Real-World Evidence.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Thrombotic and ischemic event reporting with anticoagulant reversal agents: a multi-agent FAERS pharmacovigilance study.

Journal of thrombosis and thrombolysis·2026

Longitudinal trace element monitoring in haemodialysis patients: Impact of dialysis vintage and technical treatment factors.

Clinical biochemistry·2026

Hand-powered micro-slit-gated microfluidics for concurrent blood typing and hematocrit estimation.

Biosensors & bioelectronics·2026

A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.

Blood advances·2026

Expanding the spectrum of post-HSCT hemolysis: from passenger lymphocyte syndrome to host- and graft-associated alloimmune hemolytic anemia.

Blood research·2026

Related Experiment Videos

Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha

Related Concept Videos

[Preoperative X-ray computed tomographic evaluation of major aplasia of the ear in children].

Systemic levels of tumor necrosis factor alpha during hemodialysis with cellulosic membranes: no effect of the sterilization procedure.

[Immunohistochemical findings in otosclerotic lesions].

Quantitative assessment of urinary protein and enzyme excretion--a diagnostic programme for the detection of renal involvement in type I diabetes mellitus.

Variables associated with the assessment of systemic tumor necrosis factor alpha levels during hemodialysis.

Peri-operative liver graft function: monitoring using the relationship between blood glucose and oxygen consumption during anaesthesia.

Hairy Cell Leukemia: 2026 Update on Diagnosis, Risk-Stratification, and Treatment.

Splenic Tropism and Spleen-Modulated Systemic Inflammation in Acute Plasmodium vivax Malaria.

The Presence and Percentage of Circulating Nucleated Red Blood Cells Reveal Distinct Characteristics in Adults With Sickle Cell Disease.

Anticoagulant Therapy and Bleeding-Related Hospitalizations in Patients With Cancer: A National Cohort Study.

Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

Primary Plasma Cell Leukemia.

Treatment Adherence in Haemophilia: Methods of Assessment, Clinical Outcomes, and Real-World Evidence.

Thrombotic and ischemic event reporting with anticoagulant reversal agents: a multi-agent FAERS pharmacovigilance study.

Longitudinal trace element monitoring in haemodialysis patients: Impact of dialysis vintage and technical treatment factors.

Hand-powered micro-slit-gated microfluidics for concurrent blood typing and hematocrit estimation.

A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients.

Expanding the spectrum of post-HSCT hemolysis: from passenger lymphocyte syndrome to host- and graft-associated alloimmune hemolytic anemia.

Related Experiment Videos

Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha

Related Concept Videos

Related Articles